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In 1999, the Pan American Health Organization
(PAHO),after consulting with the Directors of the Blood
Banks in the Caribbean countries and with the
Coordinators of the National Blood Programs of the
Latin American countries, prepared an action plan for
improving the safety of blood transfusion in the region
of the Americas. It clearly expressed (1) the need to
assure the quality of blood bank services in all sectors,
(2) the requirement for blood banks to participate in
programs of external evaluation of performance,and (3)
a subregional approach that was warranted in the
Caribbean countries because of the small number of
blood banks. The plan of action was approved by the
Directing Council of PAHO in October 1999.1 As part of
the initiative to strengthen blood services,the Caribbean
Epidemiology Center (CAREC), with technical and
financial support from PAHO and the collaboration of
the AABB, prepared the Caribbean Regional Standards
for Blood Banks and Transfusion Services.2 These
standards have specific sections that detail the
requirements for compatibility testing and external
quality assessments.
To bring the plan of action into operation and to
facilitate compliance with the Caribbean Regional
Standards, PAHO requested that the United Kingdom
National External Quality Assessment Scheme (UK
NEQAS) for Blood Transfusion Laboratory Practice
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Table 1. Participation in external evaluation of performance
Country Centers participating in external evaluation
Anguilla 1














St.Kitts and Nevis 2
St. Lucia 1
St.Vincent and the Grenadines 1
Suriname 1
Trinidad andTobago 3
Turks and Caicos Islands 1
*Haiti started participating in 2005.
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organize a program to assess the performance in ABO
grouping, D typing, crossmatching, antibody screening,
and antibody identification of 25 Caribbean blood
services in 20 countries (Table 1). UK NEQAS sends the
panels of unknown samples four times each year to
CAREC, which, in turn, ships the materials to each
country.
The results of the surveys from 2002 to 20053
showed improvement inABO grouping and D typing by
participating centers (Table 2). Nevertheless, in 2005,
antibody identification results were returned for only
49.5 percent of potential cases, and there were
persistent unsatisfactory reports for antibody screening
(four) and for crossmatching (seven). These prompted
the UK NEQAS to conclude that“follow-up of problems
identified by the external quality assessments is
required, in the form of education and training.”3
PAHO took on the recommendation of the UK
NEQAS to organize a hands-on,wet workshop to address
the more prevalent weaknesses among the Caribbean
blood services. The workshop was a collaboration of
the University of Maryland School of Medicine and the
American Red Cross. Reagents were donated by Ortho-
Clinical Diagnostics, Inc., Raritan, New Jersey, and
Immucor, Inc.,Norcross,Georgia.
The Workshop
Participants represented countries shown in Table
1. The workshop included both lectures and practical
sessions. The topics were designed to address external
proficiency program failures with emphasis on the most
important issues of ABO and D testing, compatibility
testing, antibody screening and crossmatching, and
antibody identification. Additional topics included
errors in transfusion medicine,a discussion on the over-
all safety of transfusion in theAmericas, and technology
recently developed for the blood transfusion service.
The number of workshop participants was 17 and the
number of contact hours was 14.
Baselining
At the start of the workshop, the participants were
surveyed using electronic ResponseCard keypads
(courtesy of Turning Technologies LLC, Youngstown,
OH) to ascertain: (1) how many laboratories participate
in the UK NEQAS,(2) the type of testing performed,and
(3) the technology, procedures, and reagents used in
their laboratories. The responses were used to adjust
the program to meet the needs of the audience.
The responses indicated that 64.7 percent of the
attendees participated in the UK NEQAS. In terms of
technology,37.5 percent reported using gel technology,
12.5 percent tube testing, 12.5 percent column
technology, and 37.5 percent a combination of
technologies. Only 27 percent of the laboratories
routinely perform all of the following tests: ABO
grouping and D typing, crossmatching, antibody
screening, and antibody identification. In terms of
antibody screening,43 percent of the laboratories use a
three-vial set (not pooled) of reagent screening RBCs,
and 14 percent use one vial of pooled group O reagent
screening RBCs. The enhancement reagents used with
the antibody screen were LISS in 42 percent of the
laboratories, albumin in 25 percent, PEG in 25 percent,
and other reagents in 8 percent. When asked what type
of crossmatches they performed, 50 percent of the
laboratories reported immediate spin (IS) if the patient
has no history of an alloantibody and a negative
antibody screen, and 50 percent reported a complete
crossmatch (IS, 37°C, and anti-human globulin).
For the practical sessions,clinical histories,samples,
standard operating procedures, and worksheets were
given to each participant for individual work. Because
the results of the proficiency survey indicated testing
failures, the participants were individually proctored at
a ratio of one proctor for four participants. Results were
tabulated using the anonymous vote-in electronic
technology (TurningPoint,Turning Technologies;Table
3). The response cards allowed instant tabulation of
results. Root causes of the problems were shared by
proctors, and the rationale for the tests, results, and
interpretations were discussed collectively. During the
first practical session there were 64 reporting
opportunities, 48 (75%) of which were correct, with 9
nonresponses (Table 3).
As further preventive action and future education,a
copy of the book Modern Blood Banking and
Transfusion Practices,4 D.M. Harmening, editor, was
given to each participant. To facilitate mentoring and
problem solving,e-mail addresses of the primary faculty
were distributed.
Evaluation
Eleven (65%) of 17 participants graded the overall
quality of the workshop as Excellent. All the comments
Table 2. Error rates (%) among participating centers, 2002–2005
Test 2002–03 2003–04 2004–05
ABO 2.5 0.0 0.5
D 4.3 2.3 0.6
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for improvement were suggestions to extend the
duration of the workshop to allow for more discussion
and interaction with the professors. As indicated by
participant responses, we believe that the workshop
achieved the objective of improving knowledge and
competencies among the participants; it also renovated
their motivation for the work they do. Furthermore,
opportunities for future clinical discussions, consul-
tations, and referrals were also established.
Discussion
The need for this workshop was precipitated by the
scores in the external quality assessment using
proficiency samples. Although the scores had improved
somewhat over time, the failure rate was too large to
depend solely on time to improve it. As a result of the
scores in the different areas, lectures, surveys, and wet
workshop samples were developed to directly impact
the problems.
Once the workshop was designed and approved,the
participants were invited and supported in travel
accommodations.
Survey data obtained at the beginning of the
workshop indicated further areas for concentration and
confirmed the topics were appropriate. Interim evalu-
ations as to topic area development and the directives
were used to allow course correction during the
workshop.
The proof of the value of the workshop and the
applicability to the participants will be unknown until
better scores in the external evaluation are observed.
Success will also rely on the participants sharing their
knowledge and training with other staff. Sixty-five
percent of the participants evaluated the workshop as
excellent,with thirty-five percent rating the program as
good.
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Table 3. Results of ABO and D determination by participants in the
workshop
Expected result No response Incorrect Correct
GroupA2 RBCs with anti-A1 5 5 6
Group B,D+ with anti-A1 (<4+) 1 0 15
Group O,D– 2 1 13
GroupAB,D+ 1 1 14
Total 9 7 48 (75%)
